Can Checkpoint Inhibitors Pave the Way for A Generation of Targeted Therapies for Autoimmune Diseases?
When I was a medical resident, a novel developmental therapy for the treatment of certain cancers was to medically shut off the blood supply and cause ischemia to the mass. [...]